Teens with advanced-stage Hodgkin lymphoma survive longer without their disease getting worse when they receive the ...

Delhi High Court has cleared the way for Zydus Lifesciences to proceed with the sale of its version of the cancer drug ...

The court directed Zydus to maintain detailed and audited records of its sales during this period so that the innovator can ...

The availability of a more affordable biosimilar is expected to improve access to advanced cancer treatment not just in major ...

The Delhi High Court has allowed Zydus Lifesciences to sell its nivolumab biosimilar, citing public interest, while directing ...

CHENNAI: A division bench of the Delhi High Court on Monday allowed Indian drugmaker Zydus Lifesciences to sell and market ...

The Delhi HC ruling does not abolish patents or endorse blanket early entry. Instead, it stresses courts may intervene ...

Nivolumab is a monoclonal antibody-based immunotherapy used in the treatment of several cancers, including lung and head-and-neck cancers| Business News ...

Reversing the standard approved dose levels of nivolumab (Opdivo) and ipilimumab (Yervoy) in metastatic melanoma led to less ...

Cytoreductive nephrectomy merits further consideration in appropriately risk-stratified, surgically fit patients with mRCC.

In a judgment of far-reaching significance for India's pharmaceutical and patent jurisprudence, the Delhi High Court has ...

Anktiva plus checkpoint inhibitor therapy demonstrated statistically significant immune restoration across two clinical ...